Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan

NCT02977312 is registered in ClinicalTrials.gov with Hikma Pharmaceuticals LLC as lead sponsor.

NCT NCT02977312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02977312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan
Lead sponsor
Hikma Pharmaceuticals LLC
Phase
Observational
Overall status
Completed
Start date
August 31, 2012
Completion date
February 28, 2015
Enrollment
91 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia, chronic phase